UNDA 220 (Seroyal USA)


Welcome to the PulseAid listing for the UNDA 220 drug offered from Seroyal USA. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Seroyal USA
NON-PROPRIETARY NAME: Grindelia, Pilocarpus, Salvia officinalis, Senega officinalis, Stramonium, Valeriana officinalis
SUBSTANCE NAME: GRINDELIA HIRSUTULA FLOWERING TOP; PILOCARPUS MICROPHYLLUS LEAF; SAGE; DATURA STRAMONIUM; VALERIAN; POLYGALA SENEGA ROOT
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-09-22
END MARKETING DATE: 0000-00-00


UNDA 220 HUMAN OTC DRUG Details:

Item DescriptionUNDA 220 from Seroyal USA
LABELER NAME: Seroyal USA
DEA SCHEDULE:
ACTIVE STRENGTH: 6; 6; 6; 6; 6; 6([hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL)
START MARKETING DATE: 2015-09-22
END MARKETING DATE: 0000-00-00
PRODUCT ID: 62106-1157_24592b37-e3d0-0d13-e054-00144ff88e88
PRODUCT NDC: 62106-1157
APPLICATION NUMBER:

Other GRINDELIA HIRSUTULA FLOWERING TOP; PILOCARPUS MICROPHYLLUS LEAF; SAGE; DATURA STRAMONIUM; VALERIAN; POLYGALA SENEGA ROOT Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Seroyal USAUNDA 220